STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
KALV
(KALV)
KALV
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
Key Metrics
As of
2025
• vs 2025
Annual
Quarterly
Core Metrics
Market Cap
$822.05M
+20.2%
P/E Ratio
-5.00
-34.3%
P/S Ratio
11.17
ROE
6059.98%
+3251.2%
ROIC
-58.89%
+35.0%
FCF Yield
-10.14%
+54.8%
Debt/Equity
-55.91
-84663.4%
Current Ratio
5.58
+4.3%
Interest Coverage
-8.88x
+72.7%
Per Share
Revenue/Share
$1.45
Net Income/Share
$-3.23
+12.6%
Operating CF/Share
$-1.60
+47.9%
Free CF/Share
$-1.64
+47.0%
Cash/Share
$5.90
+56.1%
Book Value/Share
$-0.05
-102.8%
Tangible Book/Share
$-0.05
-102.8%
Equity/Share
$-0.05
-102.8%
Interest Debt/Share
$3.36
+1278.8%
Valuation
Market Cap
$822.05M
+20.2%
Enterprise Value
$744.28M
+25.9%
P/E Ratio
-5.00
-34.3%
P/S Ratio
11.17
P/OCF Ratio
-10.07
-125.2%
P/FCF Ratio
-9.87
-121.3%
P/B Ratio
-303.23
-4330.5%
P/TB Ratio
-303.23
-4330.5%
EV/Sales
10.11
EV/EBITDA
-4.37
-28.0%
Profitability
Earnings Yield
-19.98%
+25.5%
FCF Yield
-10.14%
+54.8%
ROE
6059.98%
+3251.2%
ROIC
-58.89%
+35.0%
Return on Tangible Assets
-48.99%
+33.0%
Capital Allocation
CapEx/OCF
-2.09%
-636.8%
CapEx/Revenue
2.32%
CapEx/Depreciation
1.17
+154.6%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
-55.91
-84663.4%
Debt/Assets
0.45
+1697.0%
Net Debt/EBITDA
0.46
-14.3%
Current Ratio
5.58
+4.3%
Interest Coverage
-8.88x
+72.7%
Income Quality
0.50
-40.4%
Efficiency
Days Sales Outstanding
56 days
Days Payables Outstanding
497 days
Days Inventory
206 days
Receivables Turnover
6.51x
Payables Turnover
0.73x
Inventory Turnover
1.77x
Special Valuations
Graham Number
--
Graham Net-Net
$-0.54
-161.9%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
KalVista Pharmaceuticals, Inc.
(KALV)
$26.73
▼
-0.03 (-0.11%)
Chart
Share
Post on X
KALV
KalVista Pharmaceuticals, Inc.
(KALV)
NASDAQ
$26.73
▼
-0.03 (-0.11%)
Chart Studio
Share
KALV